Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort.
Abhimanyu GargSergio FazioP Barton DuellAlexis BaassChandrasekhar UdataTenshang JohTom RielMarina SirotaDanielle DettlingHong LiangPamela D GarzoneBarry GumbinerHong WanPublished in: Journal of the Endocrine Society (2019)
LDLR mutations were the most common cause of heterozygous FH in this North American cohort. A strikingly high proportion of FH subjects (40%) lacked mutations in known culprit genes. Identification of underlying genetic and environmental factors in mutation-negative patients is important to further our understanding of the metabolic basis of FH and other forms of severe hypercholesterolemia.